4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000152
EVP, Chf Clinical Develop Ofcr sold 5,812 shares at $70.97 ($412,486)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneider Eugene EVP, Chf Clinical Develop Ofcr | 2026-03-19 | Sale 10b5-1 | −5,812 | $70.97 | $412,486 | 63,890 | D: show line 1 in the form |
| Open-market sales · 5,812 sh · avg $70.97 · $412,486 | |||||||
Loading xslF345X06/primary_doc.xml…